Tomohiro Morio Selected Research

Tomohiro Morio Research Topics

Disease

23	Infections 01/2022 - 03/2003
12	Neoplasms (Cancer) 01/2022 - 02/2004
11	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2022 - 11/2005
10	Wiskott-Aldrich Syndrome 09/2019 - 01/2004
9	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 05/2004
9	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2019 - 12/2006
8	Common Variable Immunodeficiency 11/2020 - 02/2008
7	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021 - 11/2009
6	COVID-19 10/2022 - 01/2021
6	Inflammation (Inflammations) 06/2022 - 03/2008
6	Chronic Granulomatous Disease 01/2020 - 01/2008
6	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 05/2009
5	Primary Immunodeficiency Diseases 01/2021 - 12/2016
5	Virus Diseases (Viral Diseases) 01/2021 - 01/2007
5	Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome) 01/2018 - 03/2003
4	Pneumonia (Pneumonitis) 10/2022 - 01/2021
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022 - 02/2004
4	Leukemia 01/2021 - 02/2007
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 03/2020 - 04/2015
4	Thrombocytopenia 1 01/2015 - 01/2004
3	Opportunistic Infections (Opportunistic Infection) 07/2022 - 03/2006
3	Neuroblastoma 01/2022 - 02/2007
3	Bronchiolitis Obliterans Syndrome 12/2021 - 01/2018
3	Down Syndrome (Down's Syndrome) 01/2021 - 08/2014
3	Rheumatoid Arthritis 06/2020 - 01/2009
3	Uveitis 03/2020 - 11/2008
3	Insulin Resistance 02/2020 - 12/2017
3	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 10/2017 - 09/2013
3	Type 1 Hyper-IgM Immunodeficiency Syndrome 10/2015 - 05/2004
2	Fever (Fevers) 06/2022 - 04/2019
2	Myositis (Idiopathic Inflammatory Myopathies) 04/2022 - 01/2022
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021 - 01/2021
2	2 X-Linked Lymphoproliferative Syndrome 10/2021 - 01/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2021 - 01/2017
2	Dysbiosis 10/2021 - 01/2021
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 06/2021 - 01/2017
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2021 - 11/2016
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2021 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 03/2013
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 11/2020
2	Job Syndrome (Hyper-IgE Syndrome) 01/2021 - 01/2016
2	Lymphopenia (Lymphocytopenia) 01/2021 - 01/2013
2	Respiratory Syncytial Virus Infections 01/2021 - 08/2014
2	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 01/2021 - 01/2021
2	Thrombocytopenia (Thrombopenia) 11/2020 - 02/2013
2	Diabetes Mellitus 02/2020 - 01/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2019 - 05/2018
2	X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation 11/2019 - 01/2019
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2019 - 05/2014
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019 - 01/2018
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2019 - 01/2016
2	Epstein-Barr Virus Infections 11/2018 - 01/2018
2	Respiratory Insufficiency (Respiratory Failure) 05/2018 - 08/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 01/2016
2	Sepsis (Septicemia) 12/2017 - 01/2015

Drug/Important Bio-Agent (IBA)

12	AutoantibodiesIBA 10/2022 - 01/2009
11	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 02/2008
10	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2006
8	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2007
7	SteroidsIBA 12/2021 - 11/2006
6	Immunoglobulin G (IgG)IBA 11/2020 - 03/2006
5	Intravenous Immunoglobulins (IVIG)FDA Link 06/2022 - 03/2003
5	VaccinesIBA 06/2022 - 08/2012
5	Immunoglobulin M (IgM)IBA 01/2021 - 03/2003
5	Busulfan (Busulfex)FDA Link 01/2021 - 05/2004
5	CytokinesIBA 01/2017 - 11/2006
4	CD40 Ligand (CD40L)IBA 01/2018 - 03/2003
4	AntigensIBA 09/2017 - 08/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 05/2014
3	Rituximab (Mabthera)FDA Link 01/2022 - 02/2004
3	Messenger RNA (mRNA)IBA 11/2021 - 03/2004
3	Pharmaceutical PreparationsIBA 10/2021 - 01/2018
3	GlucocorticoidsIBA 01/2021 - 01/2019
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 12/2009
3	fludarabineIBA 01/2021 - 01/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2019 - 05/2004
3	Immunoglobulin A (IgA)IBA 04/2015 - 03/2006
3	Wiskott-Aldrich Syndrome ProteinIBA 01/2015 - 01/2004
2	Interferon Type IIBA 10/2022 - 03/2022
2	X-Linked Inhibitor of Apoptosis ProteinIBA 10/2021 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2015
2	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 09/2013
2	Palivizumab FDA Link 01/2021 - 08/2014
2	DNA Ligase ATPIBA 11/2020 - 10/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 05/2014
2	EnzymesIBA 02/2020 - 04/2019
2	STAT1 Transcription FactorIBA 01/2020 - 01/2018
2	Tacrolimus (Prograf)FDA LinkGeneric 09/2019 - 01/2008
2	Insulin ReceptorIBA 01/2019 - 12/2017
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2018 - 12/2016

Therapy/Procedure

28	Therapeutics 07/2022 - 11/2006
24	Hematopoietic Stem Cell Transplantation 12/2021 - 05/2004
15	Cell Transplantation 10/2022 - 05/2017
14	Transplantation 11/2021 - 09/2005
7	Drug Therapy (Chemotherapy) 06/2018 - 09/2005
6	Stem Cell Transplantation 02/2022 - 11/2006
4	Splenectomy 01/2022 - 04/2010
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/2017 - 01/2008
2	Transitional Care 03/2020 - 11/2018
2	Immunotherapy 01/2018 - 11/2005